Amber Therapeutics (private company)
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth servicesPharma
Business model:B2B
Amber Therapeutics is a British niotech startup developing neuromodulation therapies to treat mixed urinary incontinence (MUI)
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 100.8M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Amber Therapeutics
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
65%
|
|
![]() |
Acesion Pharma
65%
|
|
![]() |
AFYX Therapeutics
65%
|
|
![]() |
Citryll
65%
|
|
![]() |
NMD Pharma
65%
|
|
![]() |
Sanifit Therapeutics
65%
|
|
![]() |
Synklino
65%
|
|
![]() |
Theolytics
65%
|
|
![]() |
Cytoki Pharma
65%
|
|
![]() |
Causaly
65%
|
|